The association of ATP6V1E1 with adverse features such as advanced pathological stages, vascular invasion and high histologic grades, as well as elevated alpha‐fetoprotein levels, points to its role in facilitating aggressive HCC behaviour. This evidence concerns the gene ATP6V1E1 and hepatocellular carcinoma.